3-{[3-(4-Methylphenyl)-1,2,4-oxadiazol-5-yl]methyl}quinazoline-2,4(1H,3H)-dione

Catalog No. :
ACRZIV436
CAS No. :
1223889-81-3
Molecular Formula :
C18H14N4O3
Molecular Weight :
334.33

IUPAC Name:3-((3-(p-tolyl)-1,2,4-oxadiazol-5-yl)methyl)quinazoline-2,4(1H,3H)-dione

3-{[3-(4-Methylphenyl)-1,2,4-oxadiazol-5-yl]methyl}quinazoline-2,4(1H,3H)-dione structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
10mg95%$369.00Login to see priceInquiryInquiry
250mg95%$605.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-{[3-(4-Methylphenyl)-1,2,4-oxadiazol-5-yl]methyl}quinazoline-2,4(1H,3H)-dione
IUPAC Name3-((3-(p-tolyl)-1,2,4-oxadiazol-5-yl)methyl)quinazoline-2,4(1H,3H)-dione
MDL No.MFCD14703552
Molecular FormulaC18H14N4O3
Molecular Weight334.33
SMILESO=C(N1CC2=NC(C3=CC=C(C)C=C3)=NO2)NC4=C(C=CC=C4)C1=O
InChI KeyHVPKMDIMPJNMJI-UHFFFAOYSA-N
Synonym3-{[3-(4-Methylphenyl)-1,2,4-oxadiazol-5-yl]methyl}quinazoline-2,4(1H,3H)-dione;3-[[3-(4-methylphenyl)-1,2,4-oxadiazol-5-yl]methyl]-1H-quinazoline-2,4-dione;3-((3-(P-tolyl)-1,2,4-oxadiazol-5-yl)methyl)quinazoline-2,4(1H,3H)-dione;2,4(1H,3H)-Quinazolinedione, 3-[[3-(4-methylphenyl)-1,2,4-oxadiazol-5-yl]methyl]-
CAS No.1223889-81-3

Synthetic Route by SureRoute

1. ACRZIV436 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACRZIV436 route product structure diagram
    ACRZIV4361223889-81-3
Inquiry

2. ACRZIV436 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACEBWH247 route compound structure diagram
    ACEBWH24786-96-4 In Stock
  4. Then
  5. ACRZIV436 route product structure diagram
    ACRZIV4361223889-81-3
Inquiry

Comments (0)